<--- Back to Details
First PageDocument Content
Selective serotonin reuptake inhibitors / Psychiatry / Organofluorides / Tricyclic antidepressants / Antidepressant / Serotonin–norepinephrine–dopamine reuptake inhibitor / Moclobemide / Fluoxetine / Sertraline / Chemistry / Organic chemistry / Organochlorides
Date: 2015-01-05 05:33:02
Selective serotonin reuptake inhibitors
Psychiatry
Organofluorides
Tricyclic antidepressants
Antidepressant
Serotonin–norepinephrine–dopamine reuptake inhibitor
Moclobemide
Fluoxetine
Sertraline
Chemistry
Organic chemistry
Organochlorides

Evolutionof the antidepressant consumption in France, Germany and the United Kingdom

Add to Reading List

Source URL: www.irdes.fr

Download Document from Source Website

File Size: 339,18 KB

Share Document on Facebook

Similar Documents

12.10 News Feat Ketamine MH

12.10 News Feat Ketamine MH

DocID: 1gjJQ - View Document

Evolutionof the antidepressant consumption in France, Germany and the United Kingdom

Evolutionof the antidepressant consumption in France, Germany and the United Kingdom

DocID: 1fY13 - View Document

PROCEEDINGS  Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia

PROCEEDINGS Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia

DocID: 1b326 - View Document

ACADIA PHARMACEUTICALS 2014 ANNUAL REPORT >  ABOUT US We are a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and relate

ACADIA PHARMACEUTICALS 2014 ANNUAL REPORT > ABOUT US We are a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and relate

DocID: 172wi - View Document

Kwartaalbericht 1e kwartaalmei 2002  Inhoud

Kwartaalbericht 1e kwartaalmei 2002 Inhoud

DocID: 15SJj - View Document